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OPEN
 The ability of patients to receive intravenous infusions in a home setting has been an option for patients in the United States since the 1980s. The use of home infusion will continue to expand in response to the needs of an aging population, further adoption of outpatient surgical procedures, and the push to reduce health care costs. This shift is being accelerated as a result of compressed reimbursement and incentives to reduce hospital length of 
stay. Infusions in alternative sites are estimated to represent 
approximately $9 billion to $11 billion each year in US health 
care expenditures. 1 Although much of the current home 
infusion literature focuses on postoperative pain manage-
ment, the backbone of the home infusion business remains 
hydration, antibiotic delivery, and parenteral nutrition (PN), 
with treatments also including inotropes, chemotherapy, 
and immunoglobulin therapy. 2-7 Infusion delivery has moved 
from the hospital to the home not only in the United States 
but also across the world, demonstrating cost savings and 
improving patients’ quality of life. 8 , 9 
 Although hospitals have adopted pumps with drug 
libraries and medication safety software, ie, smart pumps, 
most home infusion providers (HIPs) continue to use tradi-
tional infusion pumps that don’t have drug libraries or med-
ication safety software. Smart pumps are used ideally when 
an accurate and controlled rate of infusion is required, 
such as with chemotherapy (eg, fluorouracil [5-FU] or 
PN). However, questions remain about the amount of 
work and value smart pump technology (SPT) brings to 
HIPs and whether patients will be able to use the devices 
independently. A device with the potential to increase the 
safety of infusions, while at the same time decreasing home 
care visits or calls, would improve the efficiency of the HIP’s 
 ABSTRACT 
 While hospitals have adopted smart pump technology (SPT) featuring drug libraries and medication safety software, 
most home infusion providers (HIPs) continue to use traditional infusion pumps that don’t offer drug libraries or 
medication safety software. As infusion delivery is moving from the hospital to the home, the purpose of this study 
was to determine whether SPT was a feasible alternative at both a hospital-based and a rural HIP. HIP personnel were 
trained on an ambulatory infusion pump. Patients requiring home infusion used the pump and recorded daily pump 
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operations significantly, but only if patients accepted the 
device. 
 The purpose of this study was to determine whether SPT 
is a feasible alternative (versus manual pump programming) 
to previously used, traditional “dumb” ambulatory infusion 
pump technology, in both large, urban hospital-based HIPs 
and in small rural HIPs, by evaluating the implementation 
and satisfaction of clinicians in the HIP, as well as patient 
feedback on pump use and performance in the home. 
 METHODS 
 Study Design 
 This study was a prospective, dual-center, single-arm, 
postmarket study conducted in the United States in accor-
dance with the ethical standards of the governing insti-
tutional review board (IRB) (ClinicalTrials.gov identifier 
NCT01997099). There were 2 independent phases of the 
study, conducted consecutively at each HIP. Following IRB 
approval of both phases, HIP clinicians were trained on a 
new ambulatory smart pump and medication safety soft-
ware (CADD-Solis VIP; Smiths Medical, Minneapolis, MN). 
 Phase 1 consisted of data collection to describe the pro-
cess that was used to introduce SPT to home health care 
organizations. Phase 2 included pump interaction and sat-
isfaction data collection from patients who received home 
infusion therapy with a smart pump. 
 For phase 1, clinicians documented details of their train-
ing, drug library creation, pump data entry, and validation 
efforts. Each staff member performed 10 scenarios simu-
lating pump programming, using the completed library, and 
assessed pump programming efforts. 
 The urban HIP trained patients how to use the pump, 
and clinicians subsequently answered questions about the 
implementation and patient training process. Both HIPs 
then assessed their overall workflow changes and evaluat-
ed the new system. 
 The objectives of phase 1 were to characterize the effort 
required to create a new protocol library and the ease of 
use associated with programming the pump; summarize 
and describe any possible programming errors; assess the 
home health nurses’ perceptions of patient training and 
device setup in the home; and evaluate the needed organi-
zational workflow changes when adopting the new system. 
 In phase 2, patients were enrolled if they required home 
infusion for at least 5 days and had no previous experience 
with the study device. Patients had to be 18 years of age 
or older. The study was conducted between February 2014 
and June 2014 for the first site and January 2015 to October 
2015 for the second. Patients’ personal caregivers (PCGs) 
who were primarily responsible for device interaction 
were allowed to enroll patients and agreed to comply with 
the data collection requirements. Patients or their PCGs, 
referred to hereafter as  patients, recorded pump interac-
tion details for 5 to 7 consecutive days after the infusion 
began. Patients were allowed to provide free-text feedback, 
and they completed a questionnaire on their interaction. 
 The patients were called 24 to 96 hours after the infu-
sion began to confirm pump diary completion and again at 
7 to 10 days to answer questions about overall satisfaction 
with the pump and to confirm the return of the pump diary. 
 The primary objective of phase 2 was to assess the overall 
satisfaction of patients, as rated on a 6-point Likert scale, at 
the end of the study follow-up visit. Patients’ experiences 
were prospectively considered a success if the overall satis-
faction with the pump was rated as  somewhat agree or bet-
ter and is represented as a proportion of successful patient 
experiences to all patients enrolled. Secondary objectives of 
this phase were to summarize the number of alarms report-
ed, quantify the ability of the patients to troubleshoot the 
alarms successfully without contacting the home health care 
provider, summarize any difficulties experienced with use of 
the device, and characterize the ease of use of the pump’s 
various features, as reported on a 6-point Likert scale. 
 Statistical Analyses 
 Formal hypothesis testing was not planned or completed 
for this study. Descriptive statistics were used to summarize 
data from all clinicians and patients for each phase of the 
study. Because of the different HIP sizes and the types of 
patients they served, phase 1 data were evaluated individu-
ally for each HIP. For quantitative variables, N (total sample 
size), mean, median, standard deviation, minimum, maxi-
mum, and range were reported. For qualitative variables, 
frequency and percentage were reported. 
 RESULTS 
 Phase 1 
 The clinicians who participated in the study and evaluated 
the system implementation had varying experience in the 
home infusion profession and were either pharmacists or 
nurses. 
 Library creation: large, urban hospital-based 
HIP 
 Three clinical pharmacists championed an infusion imple-
mentation team, and each spent 9 hours completing online 
training modules and in-person software and pump training 
sessions by the device manufacturer. The team began the 
library creation process by choosing general pump settings 
after physically testing and observing the actual pump. 
Protocol template settings were then selected based on 
the HIP’s preferences, being mindful of the specific popu-
lation served and the therapies typically provided. Example 
protocols were created to help determine the best way to 
describe and develop the qualifier and drug name descrip-
tions in the drug library. 
 To begin the actual library creation process, continuous and 
intermittent therapies were created first, since concentrations 
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and the compounding of these medications typically do not 
change, and it was easiest to transition the familiar standards 
into the library. PN was approached next, with the protocol 
qualifier based on a volume range, drug name, and infusion 
duration. 
 The team then created step therapy, which was designed 
based on branded dosing recommendations and rate incre-
ment increases. The qualifiers were chosen as weight 
(10-kg weight range), and the drug name was the branded 
product and concentration. Patient-controlled analgesia 
(PCA) protocols were the last created, and the team used 
broad programming (eg, hydromorphone 2 mg/mL with a 
hard upper limit of 200 mg/h) because hospice patients 
were primarily served. This approach allowed a balance 
between the need to titrate doses versus the need to have 
hard maximums. 
 The team created 266 protocols for the drug library over 
the course of 6 business days, spending a total of 27 hours 
on the process ( Table 1 ). The team had a pharmacy resident 
spend 17.5 hours entering the protocols into the safety soft-
ware and another 7.5 hours performing validation activities 
to ensure the accuracy and completeness of the protocols. 
 Library creation: small rural HIP 
 Two nurses and 1 pharmacist participated in the library 
creation process for site 2, reporting an average training 
time of 7.8 hours each, which included online modules and 
in-person training by the manufacturer. The team created a 
total of 12 protocols for its library in a total of 8 man-hours 
over 2 business days ( Table 1 ). The first step for the team 
was to document a brief overview of the facility’s current 
workflow, after which it was determined that a template 
library for each therapy type would be created, but without 
defining the drug, qualifier, or specific safety limits. After 
the 5 templates were completed, individual protocols were 
created and references consulted. 
 Continuous infusions are the most common infusions at 
the site and were created first. For continuous infusions, 
the following qualifiers were used: 44h, 5-FU; 46h, 5-FU; 
48h, 5-FU; hydration, 0.9% sodium chloride; nafcillin; Ancef 
(cefazolin). The next delivery mode selected was PCA. The 
2 qualifiers were PCA naive and tolerant. These infusions 
were rarely administered, so the site used previously used 
rates and concentrations. 
 Intermittent and step therapies on electronic ambulatory 
pumps were not common at the site and were approached 
next. Previously used infusion rates and concentrations 
were used for the protocols. Finally, taper delivery mode for 
PN was examined. The HIP used a few sets of safe parame-
ters in the template to be able to check volume and dose. 
A wide range was given to accommodate various infusion 
rates, and orders and all qualifiers were labeled PN 12 hour. 
 Pump programming and implementation 
evaluation 
 Once the library had been completed at both HIPs, clini-
cians (N  = 13) completed a total of 130 pump programming 
scenarios, using historical patient orders from the HIPs. 
Seven programming errors (5.4%) were reported during 
the validation review (during the second pharmacy review): 
3 related to the programming of the reservoir volume; 1 
had an incorrect PCA lockout time; 1 had the maximum 
doses per hour for a PCA order; 1 had an incorrect infusion 
duration; and 1 did not use the drug library that was down-
loaded on the pump, because the pump was programmed 
manually. Clinicians rated the ability to view the pump sta-
tus and view and adjust parameters on 1 screen as the most 
beneficial features of the pump. They reported with 99.2% 
(129/130) agreement that the pump was easy to program, 
and on average, they were comfortable with programming 
the device after an average of 6.85 uses. 
 Five clinicians at site 1, the large urban hospital-based 
HIP, subsequently performed a total of 28 implementations 
for the HIP’s teaching evaluations on patients requiring infu-
sions with continuous (n  = 1), intermittent (n  = 13), and 
taper (n  = 14) therapy types. The mean training time per 
patient was approximately 40 minutes, with patients having 
an excellent (n  = 13), good (n  = 14), or fair (n  = 1) under-
standing of the pump at the end of the sessions. Priming the 
pump was reported as the easiest feature to train on, and 
the most difficult was reported as resetting the reservoir 
volume. Pump features that clinicians consistently rated 
highest were the ability to view the pump status and the 
size of the pump screen. Clinicians reported that they were 
comfortable and confident training with the new pump after 
an average of 2 implementations. 
 Phase 2 
 A total of 42 patients were enrolled in the study across 
both sites, with a broad representation of ages, genders, 
and levels of experience with ambulatory infusion pumps 
( Table 2 ). All patients reported no hearing impairment; 
 TABLE 1 






Participants 3 clinical pharmacists 2 nurses  1 pharmacist 
System training time 
(mean) 9 h per person 
7.8 h per 
person 
Number of protocols 
created 266 12 
Protocol creation time 27.0 h 3.5 h 
MSS entry time 17.5 h 3.5 h 
Validation time 7.5 h 1.0 h 
Business days spent 
working on library 14 2 
 Abbreviations: h, hour(s); HIP, home infusion provider; MSS, medication safety 
software. 
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of assessing overall patient satisfaction. All experiences 
were successful, with each patient (100%) reporting overall 
satisfaction with the pump as  somewhat satisfied or better 
( Figure 1). 
 Pump diaries were returned from 39 patients reporting 
experiences from 265 total pump use days. A total of 152 
alarms were reported on 106 pump days from 28 of the 39 
patients (71.8%). Alarms were not predefined, and patients 
reported the presence of alarms differently. Some consid-
ered any notification from the pump as an alarm (eg, infu-
sion complete), while others only reported alarms that had 
an impact on therapy delivery. A breakdown of the alarm 
types and frequencies is presented in  Table 3 .  Infusion com-
plete notifications comprised 34.2% (52/152) of the total 
alarms reported. Of the 51 high-priority alarms reported, 39 
were the result of occlusion with 17 downstream (43.6%), 12 
upstream (30.8%), and 7 not specified (17.9%). One patient 
reported experiencing 10 downstream occlusion alarms in 
the same day. All 3 system fault alarms were resolved by the 
patients after removing and restoring the same batteries. 
 Patients reported on a daily basis, not per alarm, if 
they contacted the HIP for pump troubleshooting. Of the 
106 days when alarms were reported, patients were able 
42.9% (18/42) required glasses for vision impairment, and 
7.1% (3/42) reported decreased finger dexterity that could 
have an effect on pump interactions. An infusion nurse pro-
vided the patient or caregiver with pump training, including 
training with the pump’s help screens and pump operation. 
All infusions were delivered intravenously (88.1% [37/42] 
by means of a peripherally inserted central catheter; 
11.9% [5/42] via an implanted port). The types of infusions 
delivered were taper, intermittent, or continuous, using 
either an administration set (73.8%) or cassette (26.2%) 
and an air-in-line sensitivity feature set to either low or off 
( Table 2 ). Drugs administered for the taper therapy were 
all PN infusions. Intermittent therapies were primarily pen-
icillin, Unasyn, nafcillin, or piperacillin/tazobactam, and the 
continuous infusions were milrinone (n  = 1), Ancef (n = 5), 
and 5-FU (n  = 1). 
 Forty of the 42 patients (95.2%) completed the end-of-
study visit form and contributed to the primary objective 
 TABLE 2 
 Patient Demographics 
Characteristics N  = 42 
Age (years) 
 Mean (SD) 58.4 (13.3) 
 Median (min, max) 59 (24, 77) 
Gender 
 Female 21/42 (50.0%) 
 Male 21/42 (50.0%) 
Experience using an ambulatory infusion pump? 
 Yes 14/42 (33.3%) 
 No 28/42 (66.7%) 
Patient’s/caregiver’s level of understanding of the training 
instructions 
 Excellent 20/41 (48.8%) 
 Good 16/41 (39.0%) 
 Fair 5/41 (12.2%) 
Therapy 
 Taper 24/42 (57.1%) 
 Intermittent 12/42 (28.6%) 
 Continuous 6/42 (14.3%) 
Disposable used 
 Administration set 31/42 (73.8%) 
 Cassette 11/42 (26.2%) 
Air-in-line sensitivity 
 High 0/0 (0.0%) 
 Low 28/42 (66.7%) 
 Off 14/33 (33.3%) 
 Abbreviations: max, maximum; min, minimum; N, total participants; SD, standard 
deviation. 
 Figure 1  Forty of the 42 pa  ents enrolled in the study (95.2%) 
completed the end-of-study visit form and contributed to the primary 
objec  ve of assessing overall pa  ent sa  sfac  on. The 40 completed 
end-of-study visit forms indicated that experiences were successful, 
with each respondent pa  ent repor  ng overall sa  sfac  on with the 
pump as  somewhat sa  sfi ed or be  er. 
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could be applicable in large urban and in rural HIPs. SPT in 
HIPs positively had an impact on pump programming, clini-
cian workflow, and ease of use for patients in their homes. 
 The first step in the implementation of smart pumps 
was the creation of drug libraries. During this step, sever-
al improvement opportunities were identified, including 
tremendous variation in prescription labels for the same 
therapies and a lack of standardized concentrations. These 
were seen with both taper therapies and step therapies. 
With taper therapies, there was concern about ensuring 
that correct volume and duration were programmed. With 
step therapy, it was cumbersome to address specific dis-
ease-state dosing when there were different dosing param-
eters for different diagnoses, eg, chronic inflammatory 
demyelinating polyneuropathy versus primary immunodefi-
ciency for Gamunex. In these cases, the more conservative 
dosing regimen prevailed. Package inserts were also used 
to determine protocol parameters, such as initial, main-
tenance, and maximum infusion rates. A standardization 
project was initiated to address the deficiencies noted, 
resulting in the creation of standard labels and the adop-
tion of standardized concentrations. 
 The smart pump software encouraged the standard-
ization of drug concentrations and prescription labels, 
and streamlined the pump distribution process. These 
to resolve the alarms successfully without contacting the 
HIP 86.8% of the time (92 days). Of the 14 days when the 
HIP was contacted about an alarm, a total of 17 alarms 
were reported: air in line (5), occlusion (4), other (2), low 
reservoir (1), starting pump (1), infusion complete (2), sys-
tem error (1), and high pressure (1). Of the 92 days with 
alarms that did not require the patient to contact the HIP, 
patients were asked to rate the ease of resolving the alarm 
independently and indicate whether they used the help 
screens to resolve the issue. Of the questions answered, 
79/81 (97.5%) rated the ease of resolving the alarm as easy, 
and 38/82 (46.3%) used the pump help screens. 
 Table 4 describes patient-reported device difficulties. 
Fourteen of the 39 (35.9%) patients reported experiencing 
device difficulties on 23 days (8.7%). Of the areas of difficul-
ty reported, stopping alarm(s) and starting or restarting the 
pump were most common. Despite reporting difficulties 
with the pump on 23 days, the patients still reported satis-
faction with the device on 99.6% of all the device-use days. 
 Patients were also asked to rate 14 overall “ease-of-
use” statements related to their handling of the pump and 
reported 100% agreement with 10 statements and 94.3% 
to 97.5% with 4 statements. All but 1 patient (97.5%) 
agreed they would recommend the pump to others who 
needed home infusion therapy. 
 DISCUSSION 
 Medication errors can be a serious issue, and hospitals have 
been working on protocols to reduce their occurence. 10 
SPT features drug libraries and medication safety software 
that have been developed to reduce medication errors. 11 
While hospitals have adopted SPT, most HIPs are still using 
traditional infusion pumps that do not use drug libraries or 
medication safety software. This study indicates that SPT 
 TABLE 3 
 Alarms Experienced by Patients 
Alarm Type 
Alarms Reported 
N  = 152 
Low priority 
 Pump not started 2 
 Infusion completed 52 
 Low battery 6 
Medium priority 
 Low reservoir 28 
 Pump unable to be started without
 latched and locked cassette 13 
High priority 
 Occlusion 39 
 Air in line 9 
 System fault 3 
 TABLE 4 
 Patient-Reported Device 
Difficulties 
Measure 
N  = 265 Pump Use Days 
(% Infusion Days) 
Daily device or component 
 difficulties reported 23/265 (8.7%) 
Patients with device or component 
 difficulties 14/39 (35.9%) 
Area of difficulty n  = 23 areas of diffi  culty a 
 Stopping alarm(s) 8/25 (32%) 
 Starting or restarting pump 5/25 (20%) 
 Changing bag, tubing, cassette 3/25 (12%) 
 Stopping the pump 2/25 (8%) 
 Resetting infusion volume 2/25 (8%) 
 Priming tubing 2/25 (8%) 
 Changing or charging batteries 2/25 (8%) 
 Volume of infusion “complete” 
 tone too soft 1/25 (4%) 
Daily satisfaction with pump n  = 258 responses 
 Very satisfied 209/258 (81%) 
 Satisfied 42/258 (16.3%) 
 Somewhat satisfied 6/258 (2.3%) 
 Dissatisfied 1/258 (0.4%) 
 a Patients may have reported more than 1 area of difficulty per day. 
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demonstrated that SPT can be used effectively by patients 
with a high level of satisfaction. Smart pumps could be a 
feasible approach for HIPs of any size or at any location. 
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measures suggest a decreased risk of pump programming 
errors by eliminating the need to program manually or to 
copy from previous patients. Additional studies are needed 
to demonstrate an impact of these measures on drug pro-
gramming error rates. Building a library is an investment 
of time and resources that can save time and increase 
safety in the long term. The financial effects of standard-
ization were outside the scope of this study but should be 
considered for potential cost savings and improved risk 
management. 
 The user interface of the pump was robust and had a 
positive impact on the clinician’s ease of use. The increased 
ease of use may have a direct impact on the ease in patient 
teaching, as reflected by 100% of clinicians reporting that 
it is easier to teach how to use a smart pump than other 
infusion pumps. The use of drug libraries minimizes the 
need for clinicians to learn extensive pump programming. 
This allows for increased focus on fewer tasks, such as con-
firming settings with the drug label, and leads to improved 
patient safety. It is anticipated that this robust user inter-
face will facilitate the education of external or partner 
nursing agencies new to pumps. 
 Alarms were the most frequently cited difficulty associ-
ated with pump use. However, 96.5% of patients found it 
 somewhat easy to  very easy to resolve alarms using help 
screens, and 98% of the time, patients found it  somewhat 
easy to  very easy to resolve alarms without help from the 
provider. The ability to resolve alarms independently, with-
out contacting the HIP for assistance, may have a workflow 
and a financial impact, although this study did not look 
at those factors. Increased patient ease of use, low alarm 
rates, and the ability to address alarms independently 
resulted in general satisfaction with the pump. 
 CONCLUSION 
 Ambulatory SPT can be implemented successfully in large 
urban and small rural HIPs. Clinicians indicated that the 
pump was easy to use and appreciated the drug library 
creation process for improved protocol consistency with 
potential improvements in patient safety. This study also 
